Drug discovery is entering an exciting stage in China.  Many international companies have established their R&D centers in Shanghai, Beijing, Suzhou, Wuhan, and other parts of the country; More are conducting multi-center clinical trials in China; Chinese domestic companies are catching up by building and investing more and more in their own scientific teams and programs; Pharmaceutical and biotechnological start-ups with novel business models are emerging, and many more. 

DIA, a neutral and global organization with 50 years of history of excellence in providing scientific and educational meetings and programs in the pharmaceutical and other healthcare fields, will offer its 1^st conference and exhibition in Drug Discovery Innovation this coming October, which covers topics from drug design target to Phase IIA, proof of concept.  We, unlike many commercial meeting organizers, have attracted a group of world-class leaders in the fields who have both international visions and real China experience to guide us in creating the meeting programs and contents. 

Join us on October 11-14 in Shanghai to become part of this unparallel event! 

More event details and online registration, Please go to: http://en15951.eventdove.com/